Research Article Open Access DOI: 10.53043/2320-1991.acb13016

Mapping Two Decades of Mesenchymal Stromal Cell Research in Oncology: A Bibliometric and Thematic Analysis

Zhang Lei1*, Jing Li2, Yang Chen3, Jingbo Tan2,4

1Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Gaithersburg, MD, USA
2Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China
3Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, 518055, China
4Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Gaithersburg, MD, USA
Citation: Guilbert D, Zimorski N (2025) Synergistic Cell–Gene Immunotherapy: Integrating Regenerative Medicine with Advanced CGTs for Durable Treatment of Degenerative and Oncologic Diseases. Appl Cell Biol, 13(4), [92-98]
Abstract

Background: Mesenchymal stromal/stem cells (MSCs) have attracted sustained attention in oncology due to their functional plasticity and multifaceted interactions within the tumor microenvironment. Bibliometric analysis provides a quantitative framework to evaluate the evolution, maturity, and intellectual structure of a research field, as well as shifts in thematic emphasis over time. Despite the rapid expansion of MSC-related cancer research, a comprehensive bibliometric and thematic evaluation of this domain has not previously been undertaken.

Methods: Publications related to mesenchymal stromal/stem cells in oncology were retrieved from the Web of Science™ Core Collection. Bibliometric indicators, including publication output, citation performance, country and journal contributions, and cancer-type focus, were systematically analyzed. VOSviewer software was employed to construct keyword co-occurrence networks and identify major research clusters and temporal trends.

Results: A total of 9,927 publications were included in the analysis. Annual publication output demonstrated an exponential growth pattern (e = 0.97), indicating sustained expansion of the field. The United States and the People’s Republic of China contributed the highest number of publications; however, when adjusted for population size and citation impact per article, Singapore, Luxembourg, and Switzerland emerged as the most influential contributors. Over the past 15 years, 74% of publications appeared in cancer-specific journals. Among common malignancies, breast cancer accounted for the largest proportion of disease-focused studies (42%). Journals with a primary emphasis on basic science published the majority of articles (44%). Keyword co-occurrence analysis revealed three principal thematic clusters: (i) MSC characterization and nomenclature, (ii) clinical and translational applications, and (iii) molecular mechanisms and functional roles. Recent publications showed a marked shift toward molecular and mechanistic investigations.

Conclusions: Research on mesenchymal stromal/stem cells in oncology has undergone rapid and sustained growth over the past two decades. The increasing presence of MSC-focused studies in oncology-specific journals reflects broad acceptance of this research area within the cancer community. While basic and mechanistic studies currently dominate the literature, the findings highlight a clear opportunity for further development of translational and clinically oriented investigations.

Keywords

Mesenchymal stromal cells; Mesenchymal stem cells; Bibliometric analysis; Cancer; Neoplasia; Translational research.